# Xeris Biopharma Holdings, Inc. (XERS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XERS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 83.13M | $ 2.23M | $ 9.55M | N/A | $ 13.01M |
| 2025 | $ 298.82M | $ 567.2K | $ 28.30M | $ 37.76M | $ 13.69M |
| 2024 | $ 213.44M | $ -57.64M | $ -39.78M | $ 271.45M | $ -29.62M |
| 2023 | $ 177.23M | $ -67.31M | $ -54.57M | $ 229.19M | $ -6.78M |
| 2022 | $ 123.16M | $ -105.75M | $ -115.51M | $ 198.06M | $ 45.19M |
| 2021 | $ 59.20M | $ -145.88M | $ -114.85M | $ 88.07M | $ 95.23M |
| 2020 | $ 26.03M | $ -116.11M | $ -103.11M | $ 87.02M | $ 33.76M |
| 2019 | $ 3.56M | $ -162.09M | $ -136.11M | $ 58.31M | $ 14.44M |
| 2018 | $ 3.26M | $ -79.35M | $ -76.32M | $ 31.89M | $ 75.41M |
| 2017 | $ 2.10M | $ -35.77M | $ -34.17M | $ 0 | $ -57.83M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.87 |
| Liabilities / Eq | 29.13 |
| Current Ratio | 2.12 |

## Other views

- [Metrics](https://sponda.capital/en/XERS.md)
- [Charts](https://sponda.capital/en/XERS/charts.md)
- [Compare](https://sponda.capital/en/XERS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.